Chemicals - Specialty
Compare Stocks
5 / 10Stock Comparison
BCPC vs AVNT vs IOSP vs INGR vs IFF
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals - Specialty
Packaged Foods
Chemicals - Specialty
BCPC vs AVNT vs IOSP vs INGR vs IFF — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty | Packaged Foods | Chemicals - Specialty |
| Market Cap | $5.11B | $3.35B | $1.91B | $6.77B | $19.99B |
| Revenue (TTM) | $1.06B | $3.28B | $1.78B | $7.22B | $10.79B |
| Net Income (TTM) | $158M | $158M | $117M | $729M | $839M |
| Gross Margin | 36.3% | 31.7% | 27.7% | 25.3% | 35.1% |
| Operating Margin | 21.0% | 9.3% | 8.7% | 14.1% | 8.0% |
| Forward P/E | 30.9x | 12.0x | 15.5x | 9.6x | 17.8x |
| Total Debt | $192M | $1.92B | $90M | $1.79B | $6.65B |
| Cash & Equiv. | $75M | $511M | $293M | $1.03B | $590M |
BCPC vs AVNT vs IOSP vs INGR vs IFF — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Balchem Corporation (BCPC) | 100 | 158.5 | +58.5% |
| Avient Corporation (AVNT) | 100 | 147.3 | +47.3% |
| Innospec Inc. (IOSP) | 100 | 99.4 | -0.6% |
| Ingredion Incorpora… (INGR) | 100 | 127.5 | +27.5% |
| International Flavo… (IFF) | 100 | 58.8 | -41.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BCPC vs AVNT vs IOSP vs INGR vs IFF
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BCPC is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 8.8%, EPS growth 20.9%, 3Y rev CAGR 3.2%
- 160.5% 10Y total return vs IOSP's 84.4%
- 8.8% revenue growth vs IFF's -5.2%
- 15.0% margin vs AVNT's 4.8%
AVNT lags the leaders in this set but could rank higher in a more targeted comparison.
IOSP is the clearest fit if your priority is valuation efficiency.
- PEG 0.48 vs BCPC's 2.41
INGR carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 3 yrs, beta 0.25, yield 3.0%
- Lower volatility, beta 0.25, Low D/E 41.0%, current ratio 2.66x
- Beta 0.25, yield 3.0%, current ratio 2.66x
- Lower P/E (9.6x vs 17.8x)
IFF ranks third and is worth considering specifically for momentum.
- +8.5% vs INGR's -18.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.8% revenue growth vs IFF's -5.2% | |
| Value | Lower P/E (9.6x vs 17.8x) | |
| Quality / Margins | 15.0% margin vs AVNT's 4.8% | |
| Stability / Safety | Beta 0.25 vs AVNT's 1.19, lower leverage | |
| Dividends | 3.0% yield, 3-year raise streak, vs AVNT's 2.9% | |
| Momentum (1Y) | +8.5% vs INGR's -18.4% | |
| Efficiency (ROA) | 9.4% ROA vs AVNT's 2.6%, ROIC 15.5% vs 3.9% |
BCPC vs AVNT vs IOSP vs INGR vs IFF — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BCPC vs AVNT vs IOSP vs INGR vs IFF — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BCPC leads in 2 of 6 categories
INGR leads 2 • AVNT leads 0 • IOSP leads 0 • IFF leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BCPC leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
IFF is the larger business by revenue, generating $10.8B annually — 10.2x BCPC's $1.1B. BCPC is the more profitable business, keeping 15.0% of every revenue dollar as net income compared to AVNT's 4.8%. On growth, BCPC holds the edge at +8.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.1B | $3.3B | $1.8B | $7.2B | $10.8B |
| EBITDAEarnings before interest/tax | $267M | $445M | $198M | $1.2B | $1.7B |
| Net IncomeAfter-tax profit | $158M | $158M | $117M | $729M | $839M |
| Free Cash FlowCash after capex | $182M | $205M | $88M | $809M | $400M |
| Gross MarginGross profit ÷ Revenue | +36.3% | +31.7% | +27.7% | +25.3% | +35.1% |
| Operating MarginEBIT ÷ Revenue | +21.0% | +9.3% | +8.7% | +14.1% | +8.0% |
| Net MarginNet income ÷ Revenue | +15.0% | +4.8% | +6.6% | +10.1% | +7.8% |
| FCF MarginFCF ÷ Revenue | +17.2% | +6.3% | +4.9% | +11.2% | +3.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.1% | +2.5% | -2.4% | -2.4% | -3.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +10.6% | +3.8% | +167.7% | +79.0% | +116.6% |
Valuation Metrics
INGR leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 9.6x trailing earnings, INGR trades at a 77% valuation discount to AVNT's 41.0x P/E. Adjusting for growth (PEG ratio), IOSP offers better value at 0.51x vs BCPC's 2.62x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $5.1B | $3.3B | $1.9B | $6.8B | $20.0B |
| Enterprise ValueMkt cap + debt − cash | $5.2B | $4.8B | $1.7B | $7.5B | $26.1B |
| Trailing P/EPrice ÷ TTM EPS | 33.58x | 41.01x | 16.41x | 9.61x | -53.60x |
| Forward P/EPrice ÷ next-FY EPS est. | 30.87x | 11.95x | 15.45x | 9.56x | 17.84x |
| PEG RatioP/E ÷ EPS growth rate | 2.62x | — | 0.51x | 0.57x | — |
| EV / EBITDAEnterprise value multiple | 19.83x | 12.22x | 8.29x | 5.98x | 13.28x |
| Price / SalesMarket cap ÷ Revenue | 4.92x | 1.03x | 1.07x | 0.94x | 1.84x |
| Price / BookPrice ÷ Book value/share | 4.14x | 1.40x | 1.44x | 1.60x | 1.41x |
| Price / FCFMarket cap ÷ FCF | 29.51x | 17.16x | 21.68x | 13.25x | 78.09x |
Profitability & Efficiency
INGR leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
INGR delivers a 17.1% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $6 for IFF. IOSP carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to AVNT's 0.81x. On the Piotroski fundamental quality scale (0–9), BCPC scores 9/9 vs IFF's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +12.4% | +6.6% | +9.0% | +17.1% | +5.9% |
| ROA (TTM)Return on assets | +9.4% | +2.6% | +6.5% | +9.4% | +3.3% |
| ROICReturn on invested capital | +12.2% | +3.9% | +11.2% | +15.5% | +3.5% |
| ROCEReturn on capital employed | +14.8% | +4.0% | +11.0% | +16.3% | +4.4% |
| Piotroski ScoreFundamental quality 0–9 | 9 | 5 | 6 | 8 | 5 |
| Debt / EquityFinancial leverage | 0.15x | 0.81x | 0.07x | 0.41x | 0.47x |
| Net DebtTotal debt minus cash | $117M | $1.4B | -$203M | $760M | $6.1B |
| Cash & Equiv.Liquid assets | $75M | $511M | $293M | $1.0B | $590M |
| Total DebtShort + long-term debt | $192M | $1.9B | $90M | $1.8B | $6.7B |
| Interest CoverageEBIT ÷ Interest expense | 15.23x | 3.61x | — | 27.32x | 5.26x |
Total Returns (Dividends Reinvested)
BCPC leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in INGR five years ago would be worth $12,881 today (with dividends reinvested), compared to $6,190 for IFF. Over the past 12 months, IFF leads with a +8.5% total return vs INGR's -18.4%. The 3-year compound annual growth rate (CAGR) favors BCPC at 8.2% vs IOSP's -6.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +3.6% | +16.0% | +0.5% | -0.7% | +15.6% |
| 1-Year ReturnPast 12 months | -2.2% | +4.1% | -14.9% | -18.4% | +8.5% |
| 3-Year ReturnCumulative with dividends | +26.6% | +2.3% | -17.3% | +7.9% | -13.2% |
| 5-Year ReturnCumulative with dividends | +24.2% | -22.7% | -18.3% | +28.8% | -38.1% |
| 10-Year ReturnCumulative with dividends | +160.5% | +27.8% | +84.4% | +13.5% | -12.6% |
| CAGR (3Y)Annualised 3-year return | +8.2% | +0.8% | -6.1% | +2.6% | -4.6% |
Risk & Volatility
Evenly matched — INGR and IFF each lead in 1 of 2 comparable metrics.
Risk & Volatility
INGR is the less volatile stock with a 0.25 beta — it tends to amplify market swings less than AVNT's 1.19 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IFF currently trades 93.0% from its 52-week high vs INGR's 75.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.33x | 1.19x | 0.70x | 0.25x | 0.68x |
| 52-Week HighHighest price in past year | $183.90 | $44.85 | $95.55 | $141.78 | $84.19 |
| 52-Week LowLowest price in past year | $139.17 | $27.48 | $65.58 | $100.71 | $59.14 |
| % of 52W HighCurrent price vs 52-week peak | +86.7% | +81.4% | +80.2% | +75.8% | +93.0% |
| RSI (14)Momentum oscillator 0–100 | 32.9 | 55.2 | 59.1 | 27.3 | 72.5 |
| Avg Volume (50D)Average daily shares traded | 190K | 620K | 221K | 585K | 1.6M |
Analyst Outlook
Evenly matched — AVNT and INGR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BCPC as "Buy", AVNT as "Buy", IOSP as "Hold", INGR as "Hold", IFF as "Buy". Consensus price targets imply 50.1% upside for IOSP (target: $115) vs 1.6% for BCPC (target: $162). For income investors, INGR offers the higher dividend yield at 3.01% vs BCPC's 0.54%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $162.00 | $48.40 | $115.00 | $124.25 | $87.75 |
| # AnalystsCovering analysts | 10 | 20 | 9 | 21 | 33 |
| Dividend YieldAnnual dividend ÷ price | +0.5% | +2.9% | +2.2% | +3.0% | +2.0% |
| Dividend StreakConsecutive years of raises | 11 | 14 | 12 | 3 | 0 |
| Dividend / ShareAnnual DPS | $0.87 | $1.08 | $1.70 | $3.24 | $1.60 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.1% | +0.1% | 0.0% | +3.3% | +0.2% |
BCPC leads in 2 of 6 categories (Income & Cash Flow, Total Returns). INGR leads in 2 (Valuation Metrics, Profitability & Efficiency). 2 tied.
BCPC vs AVNT vs IOSP vs INGR vs IFF: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BCPC or AVNT or IOSP or INGR or IFF a better buy right now?
For growth investors, Balchem Corporation (BCPC) is the stronger pick with 8.
8% revenue growth year-over-year, versus -5. 2% for International Flavors & Fragrances Inc. (IFF). Ingredion Incorporated (INGR) offers the better valuation at 9. 6x trailing P/E (9. 6x forward), making it the more compelling value choice. Analysts rate Balchem Corporation (BCPC) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BCPC or AVNT or IOSP or INGR or IFF?
On trailing P/E, Ingredion Incorporated (INGR) is the cheapest at 9.
6x versus Avient Corporation at 41. 0x. On forward P/E, Ingredion Incorporated is actually cheaper at 9. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Innospec Inc. wins at 0. 48x versus Balchem Corporation's 2. 41x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BCPC or AVNT or IOSP or INGR or IFF?
Over the past 5 years, Ingredion Incorporated (INGR) delivered a total return of +28.
8%, compared to -38. 1% for International Flavors & Fragrances Inc. (IFF). Over 10 years, the gap is even starker: BCPC returned +160. 5% versus IFF's -12. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BCPC or AVNT or IOSP or INGR or IFF?
By beta (market sensitivity over 5 years), Ingredion Incorporated (INGR) is the lower-risk stock at 0.
25β versus Avient Corporation's 1. 19β — meaning AVNT is approximately 375% more volatile than INGR relative to the S&P 500. On balance sheet safety, Innospec Inc. (IOSP) carries a lower debt/equity ratio of 7% versus 81% for Avient Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — BCPC or AVNT or IOSP or INGR or IFF?
By revenue growth (latest reported year), Balchem Corporation (BCPC) is pulling ahead at 8.
8% versus -5. 2% for International Flavors & Fragrances Inc. (IFF). On earnings-per-share growth, the picture is similar: Innospec Inc. grew EPS 228. 9% year-over-year, compared to -253. 7% for International Flavors & Fragrances Inc.. Over a 3-year CAGR, BCPC leads at 3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BCPC or AVNT or IOSP or INGR or IFF?
Balchem Corporation (BCPC) is the more profitable company, earning 14.
9% net margin versus -3. 4% for International Flavors & Fragrances Inc. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BCPC leads at 21. 1% versus 6. 2% for AVNT. At the gross margin level — before operating expenses — BCPC leads at 35. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BCPC or AVNT or IOSP or INGR or IFF more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Innospec Inc. (IOSP) is the more undervalued stock at a PEG of 0. 48x versus Balchem Corporation's 2. 41x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Ingredion Incorporated (INGR) trades at 9. 6x forward P/E versus 30. 9x for Balchem Corporation — 21. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IOSP: 50. 1% to $115. 00.
08Which pays a better dividend — BCPC or AVNT or IOSP or INGR or IFF?
All stocks in this comparison pay dividends.
Ingredion Incorporated (INGR) offers the highest yield at 3. 0%, versus 0. 5% for Balchem Corporation (BCPC).
09Is BCPC or AVNT or IOSP or INGR or IFF better for a retirement portfolio?
For long-horizon retirement investors, Balchem Corporation (BCPC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
33), 0. 5% yield, +160. 5% 10Y return). Both have compounded well over 10 years (BCPC: +160. 5%, AVNT: +27. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BCPC and AVNT and IOSP and INGR and IFF?
These companies operate in different sectors (BCPC (Basic Materials) and AVNT (Basic Materials) and IOSP (Basic Materials) and INGR (Consumer Defensive) and IFF (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BCPC is a small-cap quality compounder stock; AVNT is a small-cap quality compounder stock; IOSP is a small-cap deep-value stock; INGR is a small-cap deep-value stock; IFF is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.